Browsing Tag
AI Diagnostics
8 posts
Lunit submits FDA filing for AI mammography model: What’s next for U.S. breast cancer screening?
Find out how Lunit’s FDA-bound artificial intelligence risk model could change breast cancer screening and prevention in the United States. Read the full story.
Can Freenome’s $1.1bn SPAC deal unlock a new chapter for blood-based multi-cancer detection?
Freenome merges with PCSC in $1.1B deal to go public as FRNM. Find out how its AI-powered blood tests could change early cancer detection.
Why Rocket Doctor AI’s interim CFO appointment could reshape its financial growth strategy
Rocket Doctor AI appoints Christopher Cherry as interim CFO and grants 1.5M equity units. Find out what this means for the firm’s growth and financial direction.
ZEISS gains CE mark for CIRRUS PathFinder AI tool to enhance ophthalmic scan decision support
ZEISS earns CE mark for CIRRUS PathFinder, its integrated AI tool for OCT scan decision support. Find out how it could change ophthalmic diagnostics.
Can AI-driven blood diagnostics redefine how consumers access personalized nutrition in 2025?
AI-powered blood diagnostics platforms like InsideTracker and Thorne HealthTech are transforming how consumers personalize nutrition. Explore what’s next.
Cube Click gains FDA approval for SMILE Dx, unlocking scalable AI revenue in the dental diagnostics sector
Cube Click wins FDA clearance for SMILE Dx, an AI-powered dental diagnostics device poised to transform imaging outcomes and recurring revenue models.
Renalytix plc terminates formal sale process amid strategic realignment and market reaction
Renalytix plc, a prominent player in artificial intelligence-enabled in vitro diagnostics, has officially terminated its Formal Sale Process,…
Owkin and AWS join forces to transform precision medicine
Owkin, a pioneering TechBio company known for combining human and artificial intelligence to tailor treatments for individual patients,…